Literature DB >> 15325850

Management of early pregnancy loss.

G C M Graziosi1, B W Mol, W M Ankum, H W Bruinse.   

Abstract

OBJECTIVES: In order to assess the available evidence on the management of early pregnancy loss, we performed a meta-analysis on the subject.
METHODS: MEDLINE and EMBASE were searched for randomized studies reporting on the effectiveness of expectant management, misoprostol treatment or curettage. Outcomes considered were 'complete evacuation', complications, duration of bleeding, pain resulting from the procedure, side effects and women's satisfaction with the procedure.
RESULTS: Thirteen studies were identified. Combined data in women with missed abortion managed expectantly or treated with misoprostol showed complete evacuation rates of 28% (49/173) (range 14-47%) and 81% (242/298) (range 60-83%), respectively. In women with incomplete abortion, these rates were 94% (31/33) (range 80-100%) and 99% (75/76) (range 99-100%), respectively.
CONCLUSION: In the management of early pregnancy loss both expectant management and misoprostol treatment reduce the need for curettage, but misoprostol treatment seems to be more effective in women with missed abortion as compared to expectant management. Copyright 2004 International Federation of Gynecology and Obstetrics

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325850     DOI: 10.1016/j.ijgo.2004.04.038

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

Review 1.  Expectant care versus surgical treatment for miscarriage.

Authors:  Kavita Nanda; Laureen M Lopez; David A Grimes; Alessandra Peloggia; Geeta Nanda
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

2.  Clinical indicators for success of misoprostol treatment after early pregnancy failure.

Authors:  C Robledo; J Zhang; J Troendle; K Barnhart; M D Creinin; C Westhoff; X Huang; M Frederick
Journal:  Int J Gynaecol Obstet       Date:  2007-06-27       Impact factor: 3.561

3.  Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise.

Authors:  Devendra Singh Kushwah; Beenu Kushwah; Mohd Tariq Salman; V K Verma
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

4.  Influence of surgical evacuation on pregnancy outcomes of subsequent embryo transfer cycle following miscarriage in an initial IVF cycle: a retrospective cohort study.

Authors:  Junan Meng; Mengchen Zhu; Wenjuan Shen; Xiaomin Huang; Haixiang Sun; Jianjun Zhou
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-08       Impact factor: 3.007

5.  Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.

Authors:  Marianne A C Verschoor; Marike Lemmers; Patrick M Bossuyt; Giuseppe C M Graziosi; Petra J Hajenius; Dave J Hendriks; Marcel A H van Hooff; Hannah S van Meurs; Brent C Opmeer; Maurits W van Tulder; Liesanne Bouwma; Ruby Catshoek; Peggy Geomini; Ellen R Klinkert; Josje Langenveld; Theodoor E Nieboer; J Marinus van der Ploeg; Celine M Radder; Taeke Spinder; Lucy F van der Voet; Ben Willem J Mol; Judith A F Huirne; Willem M Ankum
Journal:  BMC Pregnancy Childbirth       Date:  2013-05-02       Impact factor: 3.007

6.  Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.

Authors:  Libei Du; Raymond Hang Wun Li; Kristina Gemzell-Danielsson; Yan Hong Du; Li Zhang; Wei Yu Diao; Pak Chung Ho
Journal:  BMJ Open       Date:  2022-01-31       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.